James J. Elist
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
James J. Elist has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Daniel Moon
James J. Elist M.D., A Medical Corporation, Beverly Hills, USA
2 shared publicationsSteven K. Wilson
Institute for Urologic Excellence, La Quinta, USA
2 shared publicationsAdam De Fazio
Miami Men’s, Miami, USA
1 shared publicationBritney L. Atwater
Section of Urology, Dartmouth Hitchcock Medical Center, Lebanon, USA
1 shared publicationElsayed Desouky
Department of Urology, Rush University, Chicago, USA
1 shared publicationKambiz Tajkarimi
Department of Urology, Spartan Men’s Health Clinic, Leesburg, USA
1 shared publication
Latest Publications
- 4 July 2025
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 38 (5) , 438-443
Silicone penile prosthesis without suprapubic lipectomy for buried penis: a pilot study on the efficacy of HimplantTM
Adult acquired buried penis (AABP) is a condition where the penile shaft becomes concealed by surrounding tissues, often due to obesity, leading to significant physical and psychological distress. This pilot study evaluates the efficacy of HimplantTM (International Medical Devices Inc., Beverly Hills, CA, USA), a subcutaneous silicone penile prosthesis, for correcting AABP without concurrent manipulation of suprapubic fat. Twelve adult patients (mean age 39.1 ± 10.8 years) underwent HimplantTM insertion between January 2023 and May 2024. Standardized pre- and postoperative measurements showed a mean increase of 3.52 ± 0.41 cm in flaccid dorsal length and 2.78 ± 0.54 cm in midshaft girth (p < 0.0001). A non-validated follow-up questionnaire revealed that 85.7% of respondents (6/7) reported improved self-confidence in both daily life and sexual activity. The overall complication rate was low and limited to minor, conservatively managed issues; there were no penile infections, penile skin erosions, or other cases requiring implant removal. Notably, no recurrences of AABP were observed during a median follow-up period of 16.5 months. These findings suggest that HimplantTM may offer a safe, effective, and minimally invasive surgical solution for AABP, improving both functional outcomes and psychosocial well-being.
- 4 July 2025
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 38 (5) , 438-443
Silicone penile prosthesis without suprapubic lipectomy for buried penis: a pilot study on the efficacy of HimplantTM
Adult acquired buried penis (AABP) is a condition where the penile shaft becomes concealed by surrounding tissues, often due to obesity, leading to significant physical and psychological distress. This pilot study evaluates the efficacy of HimplantTM (International Medical Devices Inc., Beverly Hills, CA, USA), a subcutaneous silicone penile prosthesis, for correcting AABP without concurrent manipulation of suprapubic fat. Twelve adult patients (mean age 39.1 ± 10.8 years) underwent HimplantTM insertion between January 2023 and May 2024. Standardized pre- and postoperative measurements showed a mean increase of 3.52 ± 0.41 cm in flaccid dorsal length and 2.78 ± 0.54 cm in midshaft girth (p < 0.0001). A non-validated follow-up questionnaire revealed that 85.7% of respondents (6/7) reported improved self-confidence in both daily life and sexual activity. The overall complication rate was low and limited to minor, conservatively managed issues; there were no penile infections, penile skin erosions, or other cases requiring implant removal. Notably, no recurrences of AABP were observed during a median follow-up period of 16.5 months. These findings suggest that HimplantTM may offer a safe, effective, and minimally invasive surgical solution for AABP, improving both functional outcomes and psychosocial well-being.
- Open Access
- 5 March 2024
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 38 (3) , 247-251
Himplant® subcutaneous penile implant improves penile appearance and erectile dysfunction after radical prostatectomy: a case series
Erectile dysfunction is a major postoperative complication following radical prostatectomy. Various treatments for post- radical prostatectomy erectile dysfunction including nonsurgical phosphodiesterase-5 inhibitors, intraurethral alprostadil, intracavernosal injections and penile implant prosthesis, often yield suboptimal results. In this prospective single-center case series, we examine the efficacy and outcomes of Himplant ® , a subcutaneous silicone penile implant, placement in four patients with post-radical prostatectomy erectile dysfunction who experienced limited benefits with phosphodiesterase-5 inhibitors. Patient data including demographics, prostate cancer diagnoses, erectile dysfunction characteristics, previous treatments, and outcomes were collected. Himplant ® placement was performed in a standardized manner through a high scrotal incision in all cases. Follow-up evaluations were conducted to assess the effectiveness of the procedure and any associated complications. Patients were contacted and asked 15 questions regarding satisfaction and erectile function with the responses recorded. This study presents findings of high patient satisfaction, increases in flaccid penile length and girth, no incidence of adverse events, and improved erectile function following Himplant ® placement post-radical prostatectomy. Accordingly, we suggest Himplant ® placement in patients who are frustrated by their penile appearance and suffering from erectile dysfunction after radical prostatectomy. Further multicenter studies are warranted to validate these findings and assess long-term outcomes and patient-reported satisfaction.
- 5 March 2024
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 38 (3) , 247-251
Open AccessHimplant® subcutaneous penile implant improves penile appearance and erectile dysfunction after radical prostatectomy: a case series
Erectile dysfunction is a major postoperative complication following radical prostatectomy. Various treatments for post- radical prostatectomy erectile dysfunction including nonsurgical phosphodiesterase-5 inhibitors, intraurethral alprostadil, intracavernosal injections and penile implant prosthesis, often yield suboptimal results. In this prospective single-center case series, we examine the efficacy and outcomes of Himplant ® , a subcutaneous silicone penile implant, placement in four patients with post-radical prostatectomy erectile dysfunction who experienced limited benefits with phosphodiesterase-5 inhibitors. Patient data including demographics, prostate cancer diagnoses, erectile dysfunction characteristics, previous treatments, and outcomes were collected. Himplant ® placement was performed in a standardized manner through a high scrotal incision in all cases. Follow-up evaluations were conducted to assess the effectiveness of the procedure and any associated complications. Patients were contacted and asked 15 questions regarding satisfaction and erectile function with the responses recorded. This study presents findings of high patient satisfaction, increases in flaccid penile length and girth, no incidence of adverse events, and improved erectile function following Himplant ® placement post-radical prostatectomy. Accordingly, we suggest Himplant ® placement in patients who are frustrated by their penile appearance and suffering from erectile dysfunction after radical prostatectomy. Further multicenter studies are warranted to validate these findings and assess long-term outcomes and patient-reported satisfaction.
- Open Access
- 23 February 2024
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 38 (3) , 252-256
Use of Himplant® for correction of residual deformity following prior treatment of peyronie’s disease: a case series
Over the years, numerous non-surgical and surgical treatment options have been explored for Peyronie’s disease. Current options may result in incomplete correction of the deformity, which can be bothersome to the patient. This is a two-center case series of three patients who had previously undergone treatment for Peyronie’s disease. Patient 1 underwent plication with extratunical grafting. Patient 2 underwent a series of Xiaflex® injections and then subsequent surgical plication for residual curvature. Patient 3 underwent a series of Xiaflex® injections. The Himplant® subcutaneous silicone penile prosthesis was placed in a standardized manner through a scrotal incision in all cases to mask residual penile deformities and enhance penile girth after Peyronie’s disease treatment. Patients were contacted and asked 18 questions regarding satisfaction and erectile function with the responses recorded. This pilot study presents findings of high patient satisfaction, increases in flaccid penile length and girth, and an acceptable profile of adverse events following Himplant® placement. Based on our limited experience, we would consider offering Himplant® implantation when residual curvature is <40° and the penile indentation does not cause instability/buckling during penetrative sexual activity. Further research and larger studies are warranted to validate these findings and assess long-term outcomes and patient-reported satisfaction.
- 23 February 2024
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 38 (3) , 252-256
Open AccessUse of Himplant® for correction of residual deformity following prior treatment of peyronie’s disease: a case series
Over the years, numerous non-surgical and surgical treatment options have been explored for Peyronie’s disease. Current options may result in incomplete correction of the deformity, which can be bothersome to the patient. This is a two-center case series of three patients who had previously undergone treatment for Peyronie’s disease. Patient 1 underwent plication with extratunical grafting. Patient 2 underwent a series of Xiaflex® injections and then subsequent surgical plication for residual curvature. Patient 3 underwent a series of Xiaflex® injections. The Himplant® subcutaneous silicone penile prosthesis was placed in a standardized manner through a scrotal incision in all cases to mask residual penile deformities and enhance penile girth after Peyronie’s disease treatment. Patients were contacted and asked 18 questions regarding satisfaction and erectile function with the responses recorded. This pilot study presents findings of high patient satisfaction, increases in flaccid penile length and girth, and an acceptable profile of adverse events following Himplant® placement. Based on our limited experience, we would consider offering Himplant® implantation when residual curvature is <40° and the penile indentation does not cause instability/buckling during penetrative sexual activity. Further research and larger studies are warranted to validate these findings and assess long-term outcomes and patient-reported satisfaction.